Increased circulating levels of lipopolysaccharide binding protein in children with Escherichia coli O157:H7 hemorrhagic colitis and hemolytic uremic syndrome
- PMID: 10576911
- PMCID: PMC95773
- DOI: 10.1128/CDLI.6.5.773-773.1999
Increased circulating levels of lipopolysaccharide binding protein in children with Escherichia coli O157:H7 hemorrhagic colitis and hemolytic uremic syndrome
Figures

Similar articles
-
Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.Pediatr Res. 2002 Dec;52(6):928-34. doi: 10.1203/00006450-200212000-00019. Pediatr Res. 2002. PMID: 12438672
-
Increased serum IL-10 and endothelin levels in hemolytic uremic syndrome caused by Escherichia coli O157.Nephron. 2000 Apr;84(4):326-32. doi: 10.1159/000045607. Nephron. 2000. PMID: 10754409
-
[Hemorrhagic colitis and hemolytic uremic syndrome caused by Escherichia coli O157:H7].Ann Med Interne (Paris). 1998 Sep;149(5):288-90. Ann Med Interne (Paris). 1998. PMID: 9791563 French.
-
Emerging foodborne pathogens: enterohemorrhagic Escherichia coli.Clin Lab Sci. 1998 Sep-Oct;11(5):298-304. Clin Lab Sci. 1998. PMID: 10186955 Review.
-
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.Ann Intern Med. 1988 Nov 1;109(9):705-12. doi: 10.7326/0003-4819-109-9-705. Ann Intern Med. 1988. PMID: 3056169 Review.
Cited by
-
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.Toxins (Basel). 2020 Jan 21;12(2):67. doi: 10.3390/toxins12020067. Toxins (Basel). 2020. PMID: 31973203 Free PMC article. Review.
-
Lipopolysaccharide binding protein, interleukin-6 and C-reactive protein in acute gastrointestinal infections: value as biomarkers to reduce unnecessary antibiotic therapy.Infection. 2011 Aug;39(4):327-31. doi: 10.1007/s15010-011-0117-5. Epub 2011 Apr 27. Infection. 2011. PMID: 21523403
-
Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patients.Crit Care. 2003 Dec;7(6):R154-9. doi: 10.1186/cc2386. Epub 2003 Oct 1. Crit Care. 2003. PMID: 14624690 Free PMC article.
-
Modeling Hemolytic-Uremic Syndrome: In-Depth Characterization of Distinct Murine Models Reflecting Different Features of Human Disease.Front Immunol. 2018 Jun 25;9:1459. doi: 10.3389/fimmu.2018.01459. eCollection 2018. Front Immunol. 2018. PMID: 29988557 Free PMC article.
-
Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome.Blood. 2006 Jul 1;108(1):167-76. doi: 10.1182/blood-2005-08-3219. Epub 2006 Mar 2. Blood. 2006. PMID: 16514062 Free PMC article.
References
-
- Caroll S F, Dedrick R L, White M L. Plasma levels of lipopolysaccharide binding protein correlate with outcome in sepsis and other patients. Shock. 1997;8:101.
-
- Karpman D, connell H, Svensson M, Scheutz A, Alm P, Svanborg The role of lipopolysaccharides and Shiga-like toxin in a model of Escherichia coli O157:H7 infection. J Infect Dis. 1997;175:611–620. - PubMed
-
- Koster F, Levin J, Walker L, Tung K S K, Gilman R H, Rahaman M M, Majid M A, Islam S, Williams R C. Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med. 1979;298:927–933. - PubMed
-
- Proulx F, Litalien C, Turgeon J P, Mariscalco M M, Seidman E. Inflammatory mediators in hemorrhagic colitis and hemolytic uremic syndrome. Pediatr Inf dis J. 1998;17:899–904. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical